Drug delivery and in vivo efficacy of resveratrol from nano/submicron encapsulated formulations

碩士 === 長庚大學 === 天然藥物研究所 === 93 === Resveratrol is a naturally occurring phytoalexin found in grape, which has preventing properties in coronary heart disease. To overcome the disadvantage of high elimination in oral administration and poor solubility in application, we introduced resveratrol in thre...

Full description

Bibliographic Details
Main Authors: Liao Mei-Hui, 廖美惠
Other Authors: Fang Jia You
Format: Others
Language:zh-TW
Published: 2006
Online Access:http://ndltd.ncl.edu.tw/handle/76707393528908017956
id ndltd-TW-094CGU00553011
record_format oai_dc
spelling ndltd-TW-094CGU005530112015-10-13T10:38:05Z http://ndltd.ncl.edu.tw/handle/76707393528908017956 Drug delivery and in vivo efficacy of resveratrol from nano/submicron encapsulated formulations 白藜蘆醇於奈米/次微米級微粒劑型之藥物傳遞及生體內有效性研究 Liao Mei-Hui 廖美惠 碩士 長庚大學 天然藥物研究所 93 Resveratrol is a naturally occurring phytoalexin found in grape, which has preventing properties in coronary heart disease. To overcome the disadvantage of high elimination in oral administration and poor solubility in application, we introduced resveratrol in three different lipid emulsions vesicles with nano- or submicron-size for increasing solubility of drug and in vivo efficacy in an injectable way. The first formulation in the present study was multiple systems of lipid emulsions with liposomes made by coconut oil, soybean lecithin, glycerol formal, and non-ionic surfactant. The second formulation employed vitamin E in the oil components of the lipid emulsions system so called tocol emulsions. In the third formulation, perflouropentane gases were intrapped with coconut oil and soybean lecithin made lipid emulsion to be activated with ultrasound so called lipid-coated microbubbles. The sizes of these systems was ranged from 52 to 579 nm and decreased in the order of lipid-coated microbubbles > lipid emulsions > tocol emulsions. Lipid-coated microbubbles showed the highest drug entrapment ratio nearly 90%. The inclusion of Brij 98 and Brij 35 in lipid emulsions and tocol emulsions reduced the release rate of resveratrol and showed the good stability in thermo incubation. Adding Pluronic F-68 in lipid-coated microbubbles showed different tendency in drug release rate depend on the ratio of oil components. Treated with ultrasound significantly increased the drug released from lipid-coated microbubbles in the present of plasma. The safety of these formulations was evaluated by hemolytic experiments. Intraperitoneal injection of resveratrol entrapped in lipid emulsions and tocol emulsions dramatically decreased the vascular neointima formation after arterial injury, but not significant in the animals treated with lipid-coated microbubbles due to the unsuitable administration way. Fang Jia You 方嘉佑 2006 學位論文 ; thesis 120 zh-TW
collection NDLTD
language zh-TW
format Others
sources NDLTD
description 碩士 === 長庚大學 === 天然藥物研究所 === 93 === Resveratrol is a naturally occurring phytoalexin found in grape, which has preventing properties in coronary heart disease. To overcome the disadvantage of high elimination in oral administration and poor solubility in application, we introduced resveratrol in three different lipid emulsions vesicles with nano- or submicron-size for increasing solubility of drug and in vivo efficacy in an injectable way. The first formulation in the present study was multiple systems of lipid emulsions with liposomes made by coconut oil, soybean lecithin, glycerol formal, and non-ionic surfactant. The second formulation employed vitamin E in the oil components of the lipid emulsions system so called tocol emulsions. In the third formulation, perflouropentane gases were intrapped with coconut oil and soybean lecithin made lipid emulsion to be activated with ultrasound so called lipid-coated microbubbles. The sizes of these systems was ranged from 52 to 579 nm and decreased in the order of lipid-coated microbubbles > lipid emulsions > tocol emulsions. Lipid-coated microbubbles showed the highest drug entrapment ratio nearly 90%. The inclusion of Brij 98 and Brij 35 in lipid emulsions and tocol emulsions reduced the release rate of resveratrol and showed the good stability in thermo incubation. Adding Pluronic F-68 in lipid-coated microbubbles showed different tendency in drug release rate depend on the ratio of oil components. Treated with ultrasound significantly increased the drug released from lipid-coated microbubbles in the present of plasma. The safety of these formulations was evaluated by hemolytic experiments. Intraperitoneal injection of resveratrol entrapped in lipid emulsions and tocol emulsions dramatically decreased the vascular neointima formation after arterial injury, but not significant in the animals treated with lipid-coated microbubbles due to the unsuitable administration way.
author2 Fang Jia You
author_facet Fang Jia You
Liao Mei-Hui
廖美惠
author Liao Mei-Hui
廖美惠
spellingShingle Liao Mei-Hui
廖美惠
Drug delivery and in vivo efficacy of resveratrol from nano/submicron encapsulated formulations
author_sort Liao Mei-Hui
title Drug delivery and in vivo efficacy of resveratrol from nano/submicron encapsulated formulations
title_short Drug delivery and in vivo efficacy of resveratrol from nano/submicron encapsulated formulations
title_full Drug delivery and in vivo efficacy of resveratrol from nano/submicron encapsulated formulations
title_fullStr Drug delivery and in vivo efficacy of resveratrol from nano/submicron encapsulated formulations
title_full_unstemmed Drug delivery and in vivo efficacy of resveratrol from nano/submicron encapsulated formulations
title_sort drug delivery and in vivo efficacy of resveratrol from nano/submicron encapsulated formulations
publishDate 2006
url http://ndltd.ncl.edu.tw/handle/76707393528908017956
work_keys_str_mv AT liaomeihui drugdeliveryandinvivoefficacyofresveratrolfromnanosubmicronencapsulatedformulations
AT liàoměihuì drugdeliveryandinvivoefficacyofresveratrolfromnanosubmicronencapsulatedformulations
AT liaomeihui báilílúchúnyúnàimǐcìwēimǐjíwēilìjìxíngzhīyàowùchuándìjíshēngtǐnèiyǒuxiàoxìngyánjiū
AT liàoměihuì báilílúchúnyúnàimǐcìwēimǐjíwēilìjìxíngzhīyàowùchuándìjíshēngtǐnèiyǒuxiàoxìngyánjiū
_version_ 1716831300357193728